PUK6 Cost Effectiveness of Vibegron for the Treatment of Overactive Bladder in the United States

Autor:	P. Mudd, T.M. Klein, J.V. Chen
Rok vydání:	2021
Předmět:	medicine.medical_specialty Overactive bladder business.industry Cost effectiveness Health Policy Public Health Environmental and Occupational Health medicine medicine.disease Intensive care medicine business
Zdroj:	Value in Health. 24:S235
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.04.1174
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bc02241c91d58820090e55adf0f01bd9 https://doi.org/10.1016/j.jval.2021.04.1174 Zobrazit plný text záznamu Full Text from ScienceDirect